Otitis media vaccine - Provalis
Alternative Names: OtostatLatest Information Update: 17 Dec 2003
At a glance
- Originator Provalis
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pneumococcal infections
Most Recent Events
- 14 Jan 2003 Discontinued - Preclinical for Pneumococcal infections in Australia (unspecified route)
- 08 Aug 2002 This vaccine is still in active development
- 23 Jan 2001 SmithKline Beecham has merged with Glaxo Wellcome to form GlaxoSmithKline